Revisiting the Role of CBL in Liver Fibrosis: Unveiling the Antifibrotic Potential of CBLB inhibitor NX-1607

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-03-25 DOI:10.1016/j.jhep.2025.03.023

Kaikai Lu, Yitong Xu, Lei He, Yinqi Zhao, Xunde Xian

引用次数: 0

Abstract

Section snippets

Authors' contributions

K.L. and X.X. designed the research study; K.L., Y.X., L.H. and Y.Z. conducted experiments; K.L. analyzed data; K.L., L.H., and X.X. wrote the manuscript.

Data availability statement

The data that support the findings of this study are available from the corresponding authors upon request.

Financial support

This work was supported by the National Natural Science Foundation of China (NSFC) 82270479,82070460 and HY2021-1 to Xunde Xian; the Beijing Natural Science Foundation 7242084 to Xunde Xian; the Fundamental Research Funds for the Central Universities to Xunde Xian; Peking University Medicine plus X Pilot Program-Platform Construction Project 2024YXXLHPT010 to Xunde Xian.

Declaration of Competing Interest

The authors declare no competing interests. Please refer to the accompanying ICMJE disclosure forms for further details.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.